162 related articles for article (PubMed ID: 1458760)
1. The role of pharmacokinetics in the development of biotechnologically derived agents.
Wills RJ; Ferraiolo BL
Clin Pharmacokinet; 1992 Dec; 23(6):406-14. PubMed ID: 1458760
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodies.
Lin JH
Curr Drug Metab; 2009 Sep; 10(7):661-91. PubMed ID: 19702530
[TBL] [Abstract][Full Text] [Related]
3. Transdermal iontophoresis. Pharmacokinetic considerations.
Singh P; Maibach HI
Clin Pharmacokinet; 1994 May; 26(5):327-34. PubMed ID: 8055679
[No Abstract] [Full Text] [Related]
4. The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals.
Pettit DK; Gombotz WR
Trends Biotechnol; 1998 Aug; 16(8):343-9. PubMed ID: 9720323
[TBL] [Abstract][Full Text] [Related]
5. Prodrugs of peptides and proteins for improved formulation and delivery.
Oliyai R; Stella VJ
Annu Rev Pharmacol Toxicol; 1993; 33():521-44. PubMed ID: 8494350
[No Abstract] [Full Text] [Related]
6. Carrier-based strategies for targeting protein and peptide drugs to the lungs.
Cryan SA
AAPS J; 2005 Mar; 7(1):E20-41. PubMed ID: 16146340
[TBL] [Abstract][Full Text] [Related]
7. Rational design of agents to transiently increase paracellular permeability.
Park K
J Control Release; 2015 Jul; 210():246. PubMed ID: 26077175
[No Abstract] [Full Text] [Related]
8. Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine.
O'Hagan DT; Illum L
Crit Rev Ther Drug Carrier Syst; 1990; 7(1):35-97. PubMed ID: 2257636
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic barriers to peptide and protein absorption.
Lee VH
Crit Rev Ther Drug Carrier Syst; 1988; 5(2):69-97. PubMed ID: 3052875
[TBL] [Abstract][Full Text] [Related]
10. Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes.
Vyas SP; Venugopalan P; Sood A; Mysore N
Pharmazie; 1997 May; 52(5):339-45. PubMed ID: 9183784
[TBL] [Abstract][Full Text] [Related]
11. Oral peptide and protein delivery: unfulfilled promises?
Shen WC
Drug Discov Today; 2003 Jul; 8(14):607-8. PubMed ID: 12867138
[No Abstract] [Full Text] [Related]
12. Alternative delivery systems for peptides and proteins as drugs.
Eppstein DA; Longenecker JP
Crit Rev Ther Drug Carrier Syst; 1988; 5(2):99-139. PubMed ID: 3052876
[TBL] [Abstract][Full Text] [Related]
13. Emerging strategies for the transdermal delivery of peptide and protein drugs.
Schuetz YB; Naik A; Guy RH; Kalia YN
Expert Opin Drug Deliv; 2005 May; 2(3):533-48. PubMed ID: 16296773
[TBL] [Abstract][Full Text] [Related]
14. Drug delivery via the respiratory tract.
Byron PR; Patton JS
J Aerosol Med; 1994; 7(1):49-75. PubMed ID: 10147058
[TBL] [Abstract][Full Text] [Related]
15. Controlling the release of proteins/peptides via the pulmonary route.
Shoyele SA
Methods Mol Biol; 2008; 437():141-8. PubMed ID: 18369966
[TBL] [Abstract][Full Text] [Related]
16. Oral biodrug delivery using cell-penetrating peptide.
Khafagy el-S; Morishita M
Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
[TBL] [Abstract][Full Text] [Related]
17. Models to predict intestinal absorption of therapeutic peptides and proteins.
Antunes F; Andrade F; Ferreira D; Nielsen HM; Sarmento B
Curr Drug Metab; 2013 Jan; 14(1):4-20. PubMed ID: 21933113
[TBL] [Abstract][Full Text] [Related]
18. Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry.
Katsila T; Siskos AP; Tamvakopoulos C
Mass Spectrom Rev; 2012; 31(1):110-33. PubMed ID: 21698655
[TBL] [Abstract][Full Text] [Related]
19. Approaches towards enhanced transepithelial drug delivery.
Majumdar S; Mitra AK
Discov Med; 2006 Dec; 6(36):229-33. PubMed ID: 17250788
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic barriers for GI peptide and protein delivery.
Woodley JF
Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):61-95. PubMed ID: 7600588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
